Walgreens, CVS limit sales of children’s medications amid ‘tripledemic’

Walgreens, CVS limit sales of children’s medications amid ‘tripledemic’


A sign is placed near the section for children’s medicine, Monday, Dec.19, 2022 at a Walgreens, in New York, United States.

Fatih Aktas | Anadolu Agency | Getty Images

CVS and Walgreens are limiting how many children’s pain relief medications people can buy at once amid a winter “tripledemic” of respiratory viruses, the companies said Monday.

In a statement, CVS said it is limiting the number of pain relief medications to two. Walgreens customers can buy six over-the-counter pediatric fever reducers, the company said in a statement.

“Due to increased demand and various supplier challenges, over-the-counter pediatric fever reducing products are seeing constraint across the country,” Walgreens said.

The cap applies to products bought online or at the pharmacies, the companies said.

Walmart said in a statement that although the company has seen higher demand for pediatric medication this year, it has been able to meet that demand and no purchase limits are in place.

A spokesperson for the Department of Health and Human Services said the agency had been tracking surging demand for medication.

“Every operating division across HHS is engaged and playing a pivotal role in addressing these concerns,” the spokesperson said in a statement.

In a separate statement, the Food and Drug Administration added that it can’t require companies to manufacture medications, but it is working closely with drugmakers to “understand, mitigate and prevent or reduce the impact of intermittent or increased demand of certain products.

“The FDA understands that manufacturers expect availability to continue to increase in the near future,” the statement said.

Doctors this fall saw an early surge in respiratory illnesses among young children, with babies and preschool-age kids catching the flu and other viruses, including respiratory syncytial virus, or RSV.

Several children’s hospitals in the U.S. also recently detected a severe and invasive form of strep that has killed at least 15 children in the United Kingdom since mid-September.

NEW YORK, NY – DECEMBER 19: A person purchases medicine, Monday, Dec.19, 2022 at a Walgreens, in New York, United States.

Fatih Atkas | Anadolu Agency | Getty Images

As of Monday, 78% of the inpatient beds in nearly 5,000 hospitals across the country were filled, according to data from the Department of Health and Human Services. Nearly the same percentage of intensive care beds were in use, according to the data.

According to data posted Friday by the Centers for Disease Control and Prevention, the number of people catching the flu remained high but had declined in some areas.

The agency recorded nine pediatric deaths last week, bringing the number of children who have died from the illness this season to 30. Overall, the agency estimated 150,000 flu hospitalizations and 9,300 deaths.

The respiratory viruses have hit young children hard because many remained at home after the coronavirus pandemic hit nearly three years ago, leaving their immune systems vulnerable to common illnesses, experts have said.

Valeriya Antonshchuk contributed.



Source

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to  billion
Health

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion

A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion. OpenEvidence, based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled in $75 million from […]

Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More